New Yale science building expands possibilities
Yale researchers and students are poised to benefit from cutting-edge new facilities at the Yale Science Building (YSB). Located in the footprint of the former...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Yale researchers and students are poised to benefit from cutting-edge new facilities at the Yale Science Building (YSB). Located in the footprint of the former...
The New Haven area has become a hub for thriving and growing young bioscience companies like Arvinas and Cybrexa Therapeutics, which are working to develop...
InveniAI® Corporation has expanded its flagship AI- and ML-driven innovation monitoring platform, AlphaMeld™ to include products for pharmaceutical drug discovery and development stakeholders. TargetMeld™ and...
Rallybio reports that it has added Amanda Hayward, PhD and Lisa Sinclair to the Rallybio team. Dr. Hayward will focus on further building Rallybio’s portfolio and Ms....
IsoPlexis has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research Development Center for the advancement of intracellular proteomic pathway...
Over the course of 40 days on the International Space Station (ISS), researchers will determine the effect of microgravity on JAX’s Mighty Mice — genetically...
Connecticut Gov. Ned Lamont has named two dozen business and nonprofit executives, and several state and union officials, to a newly revamped group aimed at...
Arvinas has announced a platform data update that includes initial safety, tolerability, and pharmacokinetic data from the company’s ongoing Phase 1 clinical trials of ARV-110...
Alexion Pharmaceuticals reports that the FDA has approved ULTOMIRIS® (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA)...
Melinta Therapeutics reports that the FDA has approved BAXDELA® (delafloxacin) for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by designated susceptible...